Skip to content

Predictive value of 18F-FDG PET/CT radiomics features of androgen receptor expression in patients with breast cancer

Predictive value of 18F-FDG PET/CT radiomics features of androgen receptor expression in patients with breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062858
Enrollment
Unknown
Registered
2022-08-21
Start date
2022-08-08
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Gold Standard:Pathological diagnosis

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged beyond 18 years; 2. Without any therapy before the standard examination of 18F-FDG PET/CT; 3. With histological data (type and grade) derived from biopsy or surgical specimen; 4. With IHC examination of AR performed; 5. With complete clinical and imaging datasets.

Exclusion criteria

Exclusion criteria: 1. 18F-FDG PET/CT images were incomplete or with poor imaging quality; 2. Breast lesion size was too small for segmentation; 3. Patients with other types of cancers; 4. Receptor status without clear histologically proven.

Design outcomes

Primary

MeasureTime frame
androgen receptor;

Countries

China

Contacts

Public ContactDeng Shengming

The First Affiliated Hospital of Soochow University

dshming@163.com+86 15051510189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026